SERM

Bazedoxifene is a selective estrogen receptor modulator, or SERM, the same category as Eli Lilly & Co.'s Evista, which is approved to prevent and treat osteoporosis.

Pfizer Set to Seek Aprela Nod Peter Loftus 2012

A SERM is designed to provide the benefits of estrogen while mitigating the negative effects of estrogen such as increased risk of uterine cancer.

Pfizer Set to Seek Aprela Nod Peter Loftus 2012

The selective estrogen receptor modulator (SERM), says the

Printing: Wyeth Is As Contrite As AIG 2010

The selective estrogen receptor modulator (SERM), says the

Wyeth Is As Contrite As AIG 2010

The selective estrogen receptor modulator (SERM), says the

Wyeth Is As Contrite As AIG 2010

It turns out that 27HC acts like a natural SERM (selective estrogen receptor modulator) that blocks estrogen receptors in blood vessels.

Menopause News Round-Up aka TBTAM 2007

Evista: A so-called selective estrogen receptor modulator (or SERM), Evista (raloxifene) can reduce bone loss and the risk of breast cancer.

Be Good To Your Bones 2007

This property of 27HC makes it a “selective estrogen receptor modulator,” or SERM, the first such naturally occurring molecule known to exhibit such selectivity....except to stop oestrogen from binding to those receptors.

Yet Another Part of the Puzzle Zoe Brain 2007

And when 20 million women quit HRT in the early 2000's, marketing Evista (raloxifene), a selective estrogen receptor modulator (SERM), as a kind of anti estrogen or good estrogen made sense.

FDA Official Leaves as He Came in: Serving Wall Street 2007

Both bisphosphonates, like Fosamax, Actonel, and Boniva, and raloxifene Evista, which is a selective estrogen receptor modulator or SERM, have been approved by the Food and Drug Administration to prevent bone loss and fractures.

Our Bodies, Ourselves: Menopause M.D. Vivian Pinn 2006